Scott Howard Deckelbaum, DO | |
248 Pleasant St Ste 2800, Concord, NH 03301-7529 | |
(603) 415-6464 | |
(603) 227-7576 |
Full Name | Scott Howard Deckelbaum |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 21 Years |
Location | 248 Pleasant St Ste 2800, Concord, New Hampshire |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730100892 | NPI | - | NPPES |
02806417 | Medicaid | NY |
Facility Name | Location | Facility Type |
---|---|---|
Concord Hospital | Concord, NH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Concord Hospital Inc | 6103721790 | 462 |
News Archive
What comes naturally to most people - to think and then do - is difficult for stroke patients who have lost the full use of their limbs. New research by Rice University, the University of Houston (UH) and TIRR Memorial Hermann aims to help victims recover that ability to the fullest extent possible with a $1.17 million grant from the National Institutes of Health (NIH) and the President's National Robotics Initiative (NRI).
Helicos BioSciences Corporation today announced the completion of the sale of a HelicosĀ® Single Molecule System to the St. Laurent Institute (SLI). The installation of the system is expected to be completed in early February.
Incarcerated individuals with chronic hepatitis C virus infection can be successfully treated with pegylated interferon and ribavirin, achieving similar rates of treatment completion and sustained viral response to that of infected individuals in the community, study results show.
In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make hospitalization and the need for supplemental oxygen less likely.
A donated heart can now be transported and preserved for longer than what has previously been possible. The new method, which consists of a specially designed heart box, was used for a transplant for the first time as early as the summer of 2017.
› Verified 6 days ago
Entity Name | Concord Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1194778571 PECOS PAC ID: 6103721790 Enrollment ID: O20040405000916 |
News Archive
What comes naturally to most people - to think and then do - is difficult for stroke patients who have lost the full use of their limbs. New research by Rice University, the University of Houston (UH) and TIRR Memorial Hermann aims to help victims recover that ability to the fullest extent possible with a $1.17 million grant from the National Institutes of Health (NIH) and the President's National Robotics Initiative (NRI).
Helicos BioSciences Corporation today announced the completion of the sale of a HelicosĀ® Single Molecule System to the St. Laurent Institute (SLI). The installation of the system is expected to be completed in early February.
Incarcerated individuals with chronic hepatitis C virus infection can be successfully treated with pegylated interferon and ribavirin, achieving similar rates of treatment completion and sustained viral response to that of infected individuals in the community, study results show.
In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make hospitalization and the need for supplemental oxygen less likely.
A donated heart can now be transported and preserved for longer than what has previously been possible. The new method, which consists of a specially designed heart box, was used for a transplant for the first time as early as the summer of 2017.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Scott Howard Deckelbaum, DO 248 Pleasant St Ste 2800, Concord, NH 03301-7529 Ph: (603) 415-6464 | Scott Howard Deckelbaum, DO 248 Pleasant St Ste 2800, Concord, NH 03301-7529 Ph: (603) 415-6464 |
News Archive
What comes naturally to most people - to think and then do - is difficult for stroke patients who have lost the full use of their limbs. New research by Rice University, the University of Houston (UH) and TIRR Memorial Hermann aims to help victims recover that ability to the fullest extent possible with a $1.17 million grant from the National Institutes of Health (NIH) and the President's National Robotics Initiative (NRI).
Helicos BioSciences Corporation today announced the completion of the sale of a HelicosĀ® Single Molecule System to the St. Laurent Institute (SLI). The installation of the system is expected to be completed in early February.
Incarcerated individuals with chronic hepatitis C virus infection can be successfully treated with pegylated interferon and ribavirin, achieving similar rates of treatment completion and sustained viral response to that of infected individuals in the community, study results show.
In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make hospitalization and the need for supplemental oxygen less likely.
A donated heart can now be transported and preserved for longer than what has previously been possible. The new method, which consists of a specially designed heart box, was used for a transplant for the first time as early as the summer of 2017.
› Verified 6 days ago
Nava Chana Greenfield, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 253 Pleasant St, Concord, NH 03301 Phone: 603-226-6119 | |
Andrew Kim, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 253 Pleasant St, Dartmouth Hitchcock - Dermatology, Concord, NH 03301 Phone: 603-226-6119 | |
Dr. Peter Jonathan Sands, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 253 Pleasant St, Concord, NH 03301 Phone: 603-226-2200 | |
Stephen Mark Delgiudice, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 253 Pleasant St, Concord, NH 03301 Phone: 603-226-2200 | |
Dr. Paul Dacy Espy, MD Dermatology Medicare: Medicare Enrolled Practice Location: 253 Pleasant St, Dartmouth Hitchcock - Dermatology, Concord, NH 03301 Phone: 603-229-5200 | |
Alexandra E Charos, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 248 Pleasant St Ste 2800, Concord, NH 03301 Phone: 603-415-6464 Fax: 603-227-7576 |